DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Lhomme C et al.
Phase III study of valspodar (PSC833) combined with paclitaxel and carboplatin
compared with paclitaxel and carboplatin alone in patients with stage IV or
suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal
cancer.
J Clin Oncol 2008;
26: 2674-2682
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.